| Package | Version | Identity | Name/Title | Status | FMM | WG | Date | Usage # |
|---|
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-ImmunizationEvaluation.immunizationEvent.json | R5: Immunization being evaluated (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-ImmunizationEvaluation.patient.json | R5: Who this evaluation is for (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-ImmunizationEvaluation.seriesDoses.json | R5: Recommended number of doses for immunity (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-ImmunizationEvaluation.series.json | R5: Name of vaccine series (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-ImmunizationEvaluation.status.json | R5: completed | entered-in-error (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-ImmunizationEvaluation.targetDisease.json | R5: The vaccine preventable disease schedule being evaluated (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-IR.rec.cVC.json | R5: Vaccine which is contraindicated to fulfill the recommendation (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-IR.rec.doseNumber.json | R5: Recommended dose number within series additional types | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-IR.rec.forecastReason.json | R5: Vaccine administration status reason (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-ImplementationGuide.contact.json | R5: contact additional types | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-ImplementationGuide.def.page.json | R5: Page/Section in the Guide (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-ImplementationGuide.def.par.code.json | R5: Code that identifies parameter additional types | trial-use | 0 | fhir | 2026-03 | 3 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-ImplementationGuide.definition.json | R5: Information needed to build the IG (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-ImplementationGuide.glo.profile.json | R5: profile additional types | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-ImplementationGuide.license.json | R5: SPDX license code for this IG (or not-open-source) (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-ImplementationGuide.manifest.json | R5: Information about an assembled IG (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-ImplementationGuide.packageId.json | R5: NPM Package name for IG (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-ImplementationGuide.title.json | R5: Name for this implementation guide (human friendly) (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-Ingredient.allergenicIndicator.json | R5: If the ingredient is a known or suspected allergen (new) | trial-use | 0 | fhir | 2026-03 | 3 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-Ingredient.comment.json | R5: A place for providing any notes that are relevant to the component, e.g. removed during process, adjusted for loss on drying (new) | trial-use | 0 | fhir | 2026-03 | 4 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-Ingredient.for.json | R5: The product which this ingredient is a constituent part of (new) | trial-use | 0 | fhir | 2026-03 | 3 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-Ingredient.function.json | R5: Precise action within the drug product, e.g. antioxidant, alkalizing agent (new) | trial-use | 0 | fhir | 2026-03 | 3 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-Ingredient.group.json | R5: A classification of the ingredient according to where in the physical item it tends to be used, such the outer shell of a tablet, inner body or ink (new) | trial-use | 0 | fhir | 2026-03 | 4 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-Ingredient.manufacturer.json | R5: An organization that manufactures this ingredient (new) | trial-use | 0 | fhir | 2026-03 | 3 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-Ingredient.role.json | R5: Purpose of the ingredient within the product, e.g. active, inactive (new) | trial-use | 0 | fhir | 2026-03 | 3 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-Ingredient.status.json | R5: draft | active | retired | unknown (new) | trial-use | 0 | fhir | 2026-03 | 3 |
| hl7.fhir.uv.xver-r5.r4b | R4B | StructureDefinition/StructureDefinition-ext-R5-Ingredient.sub.str.basis.json | R5: A code that indicates if the strength is, for example, based on the ingredient substance as stated or on the substance base (when the ingredient is a salt) (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r5.r4b | R4B | StructureDefinition/StructureDefinition-ext-R5-Ingredient.sub.str.concentration.json | R5: concentration additional types | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r5.r4b | R4B | StructureDefinition/StructureDefinition-ext-R5-Ingredient.sub.str.presentation.json | R5: presentation additional types | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r5.r4b | R4B | StructureDefinition/StructureDefinition-ext-R5-Ingredient.sub.str.ref.strength.json | R5: strength additional types | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-Ingredient.substance.json | R5: The substance that comprises this ingredient (new) | trial-use | 0 | fhir | 2026-03 | 3 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-InsurancePlan.administeredBy.json | R5: Product administrator (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-InsurancePlan.alias.json | R5: Alternate names (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-InsurancePlan.coverageArea.json | R5: Where product applies (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-InsurancePlan.coverage.json | R5: Coverage details (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-InsurancePlan.endpoint.json | R5: Technical endpoint (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-InsurancePlan.name.json | R5: Official name (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-InsurancePlan.network.json | R5: What networks are Included (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-InsurancePlan.ownedBy.json | R5: Product issuer (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-InsurancePlan.period.json | R5: When the product is available (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-InsurancePlan.plan.json | R5: Plan details (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-InsurancePlan.status.json | R5: draft | active | retired | unknown (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-InsurancePlan.type.json | R5: Kind of product (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-InventoryItem.association.json | R5: Association with other items or products (new) | trial-use | 0 | fhir | 2026-03 | 4 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-InventoryItem.baseUnit.json | R5: The base unit of measure - the unit in which the product is used or counted (new) | trial-use | 0 | fhir | 2026-03 | 4 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-InventoryItem.category.json | R5: Category or class of the item (new) | trial-use | 0 | fhir | 2026-03 | 4 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-InventoryItem.characteristic.json | R5: Characteristic of the item (new) | trial-use | 0 | fhir | 2026-03 | 4 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-InventoryItem.code.json | R5: Code designating the specific type of item (new) | trial-use | 0 | fhir | 2026-03 | 4 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-InventoryItem.description.json | R5: Descriptive characteristics of the item (new) | trial-use | 0 | fhir | 2026-03 | 4 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-InventoryItem.instance.json | R5: Instances or occurrences of the product (new) | trial-use | 0 | fhir | 2026-03 | 4 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-InventoryItem.inventoryStatus.json | R5: The usage status like recalled, in use, discarded (new) | trial-use | 0 | fhir | 2026-03 | 4 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-InventoryItem.name.json | R5: The item name(s) - the brand name, or common name, functional name, generic name or others (new) | trial-use | 0 | fhir | 2026-03 | 4 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-InventoryItem.netContent.json | R5: Net content or amount present in the item (new) | trial-use | 0 | fhir | 2026-03 | 4 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-InventoryItem.productReference.json | R5: Link to a product resource used in clinical workflows (new) | trial-use | 0 | fhir | 2026-03 | 4 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-InventoryItem.responsibleOrganization.json | R5: Organization(s) responsible for the product (new) | trial-use | 0 | fhir | 2026-03 | 4 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-InventoryItem.status.json | R5: active | inactive | entered-in-error | unknown (new) | trial-use | 0 | fhir | 2026-03 | 4 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-InventoryReport.countType.json | R5: snapshot | difference (new) | trial-use | 0 | fhir | 2026-03 | 4 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-InventoryReport.inventoryListing.json | R5: An inventory listing section (grouped by any of the attributes) (new) | trial-use | 0 | fhir | 2026-03 | 4 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-InventoryReport.note.json | R5: A note associated with the InventoryReport (new) | trial-use | 0 | fhir | 2026-03 | 4 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-InventoryReport.operationTypeReason.json | R5: The reason for this count - regular count, ad-hoc count, new arrivals, etc (new) | trial-use | 0 | fhir | 2026-03 | 4 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-InventoryReport.operationType.json | R5: addition | subtraction (new) | trial-use | 0 | fhir | 2026-03 | 4 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-InventoryReport.reportedDateTime.json | R5: When the report has been submitted (new) | trial-use | 0 | fhir | 2026-03 | 4 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-InventoryReport.reporter.json | R5: Who submits the report (new) | trial-use | 0 | fhir | 2026-03 | 4 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-InventoryReport.reportingPeriod.json | R5: The period the report refers to (new) | trial-use | 0 | fhir | 2026-03 | 4 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-InventoryReport.status.json | R5: draft | requested | active | entered-in-error (new) | trial-use | 0 | fhir | 2026-03 | 4 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-Invoice.account.json | R5: Account that is being balanced (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-Invoice.cancelledReason.json | R5: Reason for cancellation of this Invoice (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-Invoice.date.json | R5: DEPRICATED (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-Invoice.issuer.json | R5: Issuing Organization of Invoice (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-Invoice.lineItem.json | R5: Line items of this Invoice (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-Invoice.note.json | R5: Comments made about the invoice (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-Invoice.participant.json | R5: Participant in creation of this Invoice (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-Invoice.paymentTerms.json | R5: Payment details (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-Invoice.recipient.json | R5: Recipient of this invoice (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-Invoice.status.json | R5: draft | issued | balanced | cancelled | entered-in-error (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-Invoice.totalGross.json | R5: Gross total of this Invoice (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-Invoice.totalNet.json | R5: Net total of this Invoice (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-Invoice.type.json | R5: Type of Invoice (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-Library.author.json | R5: Who authored the content additional types | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-Library.contact.json | R5: contact additional types | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-Library.editor.json | R5: Who edited the content additional types | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-Library.endorser.json | R5: Who endorsed the content additional types | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-Library.reviewer.json | R5: Who reviewed the content additional types | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-Library.subject.json | R5: Type of individual the library content is focused on (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-Library.subtitle.json | R5: Subordinate title of the library (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-ManufacturedItemDefinition.component.json | R5: Physical parts of the manufactured item, that it is intrisically made from. This is distinct from the ingredients that are part of its chemical makeup (new) | trial-use | 0 | fhir | 2026-03 | 4 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-ManufacturedItemDefinition.ingredient.json | R5: The ingredients of this manufactured item. Only needed if these are not specified by incoming references from the Ingredient resource (new) | trial-use | 0 | fhir | 2026-03 | 3 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-MID.manufacturedDoseForm.json | R5: Dose form as manufactured (before any necessary transformation) (new) | trial-use | 0 | fhir | 2026-03 | 3 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-ManufacturedItemDefinition.manufacturer.json | R5: Manufacturer of the item, one of several possible (new) | trial-use | 0 | fhir | 2026-03 | 3 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-ManufacturedItemDefinition.marketingStatus.json | R5: Allows specifying that an item is on the market for sale, or that it is not available, and the dates and locations associated (new) | trial-use | 0 | fhir | 2026-03 | 4 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-ManufacturedItemDefinition.name.json | R5: A descriptive name applied to this item (new) | trial-use | 0 | fhir | 2026-03 | 4 |
| hl7.fhir.uv.xver-r5.r4b | R4B | StructureDefinition/StructureDefinition-ext-R5-MID.pro.value.json | R5: value additional types | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-ManufacturedItemDefinition.property.json | R5: General characteristics of this item (new) | trial-use | 0 | fhir | 2026-03 | 4 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-ManufacturedItemDefinition.status.json | R5: draft | active | retired | unknown (new) | trial-use | 0 | fhir | 2026-03 | 3 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-ManufacturedItemDefinition.unitOfPresentation.json | R5: The “real-world” units in which the quantity of the item is described (new) | trial-use | 0 | fhir | 2026-03 | 3 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-MarketingStatus.country.json | R5: The country in which the marketing authorization has been granted shall be specified It should be specified using the ISO 3166 ‑ 1 alpha-2 code elements (new) | trial-use | 0 | fhir | 2026-03 | |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-MarketingStatus.dateRange.json | R5: The date when the Medicinal Product is placed on the market by the Marketing Authorization Holder (or where applicable, the manufacturer/distributor) in a country and/or jurisdiction shall be provided A complete date consisting of day, month and year shall be specified using the ISO 8601 date format NOTE “Placed on the market” refers to the release of the Medicinal Product into the distribution chain (new) | trial-use | 0 | fhir | 2026-03 | |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-MarketingStatus.jurisdiction.json | R5: Where a Medicines Regulatory Agency has granted a marketing authorization for which specific provisions within a jurisdiction apply, the jurisdiction can be specified using an appropriate controlled terminology The controlled term and the controlled term identifier shall be specified (new) | trial-use | 0 | fhir | 2026-03 | |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-MarketingStatus.restoreDate.json | R5: The date when the Medicinal Product is placed on the market by the Marketing Authorization Holder (or where applicable, the manufacturer/distributor) in a country and/or jurisdiction shall be provided A complete date consisting of day, month and year shall be specified using the ISO 8601 date format NOTE “Placed on the market” refers to the release of the Medicinal Product into the distribution chain (new) | trial-use | 0 | fhir | 2026-03 | |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-MarketingStatus.status.json | R5: This attribute provides information on the status of the marketing of the medicinal product See ISO/TS 20443 for more information and examples (new) | trial-use | 0 | fhir | 2026-03 | |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-Measure.author.json | R5: Who authored the content additional types | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-Measure.contact.json | R5: contact additional types | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-Measure.editor.json | R5: Who edited the content additional types | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-Measure.endorser.json | R5: Who endorsed the content additional types | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-Measure.gro.code.json | R5: Meaning of the group additional types | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-Measure.gro.str.code.json | R5: Meaning of the stratifier additional types | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-Measure.gro.str.component.json | R5: Stratifier criteria component for the measure (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-Measure.gro.str.description.json | R5: The human readable description of this stratifier (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-Measure.improvementNotation.json | R5: increase | decrease additional types | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-Measure.library.json | R5: library additional types | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-Measure.reviewer.json | R5: Who reviewed the content additional types | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-Measure.subject.json | R5: E.g. Patient, Practitioner, RelatedPerson, Organization, Location, Device (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-Measure.subtitle.json | R5: Subordinate title of the measure (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-Measure.sup.code.json | R5: Meaning of the supplemental data additional types | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-Measure.sup.description.json | R5: The human readable description of this supplemental data (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-MeasureReport.gro.code.json | R5: Meaning of the group additional types | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-MeasureReport.gro.str.code.json | R5: code additional types | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-MeasureReport.gro.str.str.component.json | R5: Stratifier component values (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-MeasureReport.improvementNotation.json | R5: increase | decrease (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-MeasureReport.measure.json | R5: What measure was calculated additional types | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-MeasureReport.type.json | R5: individual | subject-list | summary | data-exchange | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-Medication.batch.json | R5: Details about packaged medications (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-Medication.identifier.json | R5: Business identifier for this medication (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-MA.per.function.json | R5: Type of performance (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-MedicationAdministration.statusReason.json | R5: Reason administration not performed (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-MedicationAdministration.status.json | R5: in-progress | not-done | on-hold | completed | entered-in-error | stopped | unknown additional codes | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-MedicationDispense.per.function.json | R5: Who performed the dispense and what they did (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-MedicationDispense.status.json | R5: preparation | in-progress | cancelled | on-hold | completed | entered-in-error | stopped | declined | unknown additional codes | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-MedicationKnowledge.associatedMedication.json | R5: The set of medication resources that are associated with this medication (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-MedicationKnowledge.code.json | R5: Code that identifies this medication (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-MedicationKnowledge.cost.json | R5: cost | trial-use | 0 | fhir | 2026-03 | 4 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-MedicationKnowledge.def.definition.json | R5: Definitional resources that provide more information about this medication (new) | trial-use | 0 | fhir | 2026-03 | 3 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-MedicationKnowledge.def.dru.value.json | R5: value additional types | trial-use | 0 | fhir | 2026-03 | 3 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-MedicationKnowledge.def.ing.strength.json | R5: strength additional types | trial-use | 0 | fhir | 2026-03 | 3 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-MedicationKnowledge.def.ing.type.json | R5: A code that defines the type of ingredient, active, base, etc (new) | trial-use | 0 | fhir | 2026-03 | 3 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-MedicationKnowledge.ind.dosingGuideline.json | R5: Guidelines for dosage of the medication (new) | trial-use | 0 | fhir | 2026-03 | 3 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-MedicationKnowledge.medicineClassification.json | R5: Categorization of the medication within a formulary or classification system (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-MedicationKnowledge.monitoringProgram.json | R5: Program under which a medication is reviewed (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-MedicationKnowledge.monograph.json | R5: Associated documentation about the medication (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-MedicationKnowledge.pac.packagedProduct.json | R5: The packaged medication that is being priced (new) | trial-use | 0 | fhir | 2026-03 | 3 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-MedicationKnowledge.preparationInstruction.json | R5: The instructions for preparing the medication (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-MedicationKnowledge.productType.json | R5: Category of the medication or product (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-MedicationKnowledge.regulatory.json | R5: Regulatory information about a medication (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-MedicationKnowledge.rMK.json | R5: Associated or related medication information (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-MedicationRequest.courseOfTherapyType.json | R5: Overall pattern of medication administration (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-MedicationRequest.dis.dispenseInterval.json | R5: Minimum period of time between dispenses (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-MedicationRequest.dis.initialFill.json | R5: First fill details (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-MedicationRequest.dis.nORA.json | R5: numberOfRepeatsAllowed additional types | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-MedicationRequest.doNotPerform.json | R5: True if patient is to stop taking or not to start taking the medication (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-MedicationRequest.insurance.json | R5: Associated insurance coverage (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-MedicationRequest.intent.json | R5: proposal | plan | order | original-order | reflex-order | filler-order | instance-order | option | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-MedicationRequest.performerType.json | R5: Desired kind of performer of the medication administration (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-MedicationRequest.reported.json | R5: Reported rather than primary record (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-MedicationRequest.statusReason.json | R5: Reason for current status (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-MedicationRequest.sub.allowed.json | R5: Whether substitution is allowed or not additional types | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-MedicationStatement.status.json | R5: recorded | entered-in-error | draft additional codes | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-MPD.aMI.json | R5: Whether the Medicinal Product is subject to additional monitoring for regulatory reasons (new) | trial-use | 0 | fhir | 2026-03 | 2 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-MedicinalProductDefinition.attachedDocument.json | R5: Additional documentation about the medicinal product (new) | trial-use | 0 | fhir | 2026-03 | 2 |
| hl7.fhir.uv.xver-r5.r4b | R4B | StructureDefinition/StructureDefinition-ext-R5-MPD.cha.value.json | R5: value additional types | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-MedicinalProductDefinition.characteristic.json | R5: Key product features such as "sugar free", "modified release" (new) | trial-use | 0 | fhir | 2026-03 | 4 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-MedicinalProductDefinition.classification.json | R5: Allows the product to be classified by various systems (new) | trial-use | 0 | fhir | 2026-03 | 4 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-MedicinalProductDefinition.clinicalTrial.json | R5: Clinical trials or studies that this product is involved in (new) | trial-use | 0 | fhir | 2026-03 | 2 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-MedicinalProductDefinition.code.json | R5: A code that this product is known by, within some formal terminology (new) | trial-use | 0 | fhir | 2026-03 | 4 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-MPD.cPDF.json | R5: The dose form for a single part product, or combined form of a multiple part product (new) | trial-use | 0 | fhir | 2026-03 | 2 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-MedicinalProductDefinition.comprisedOf.json | R5: Types of medicinal manufactured items and/or devices that this product consists of, such as tablets, capsule, or syringes (new) | trial-use | 0 | fhir | 2026-03 | 5 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-MPD.con.contact.json | R5: A product specific contact, person (in a role), or an organization (new) | trial-use | 0 | fhir | 2026-03 | 2 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-MPD.con.type.json | R5: Allows the contact to be classified, for example QPPV, Pharmacovigilance Enquiry Information (new) | trial-use | 0 | fhir | 2026-03 | 2 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-MedicinalProductDefinition.contact.json | R5: A product specific contact, person (in a role), or an organization (new) | trial-use | 0 | fhir | 2026-03 | 2 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-MPD.cro.product.json | R5: Reference to another product, e.g. for linking authorised to investigational product (new) | trial-use | 0 | fhir | 2026-03 | 2 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-MPD.cro.type.json | R5: The type of relationship, for instance branded to generic or virtual to actual product (new) | trial-use | 0 | fhir | 2026-03 | 2 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-MedicinalProductDefinition.crossReference.json | R5: Reference to another product, e.g. for linking authorised to investigational product (new) | trial-use | 0 | fhir | 2026-03 | 2 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-MedicinalProductDefinition.description.json | R5: General description of this product (new) | trial-use | 0 | fhir | 2026-03 | 4 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-MedicinalProductDefinition.domain.json | R5: domain additional types | trial-use | 0 | fhir | 2026-03 | 4 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-MedicinalProductDefinition.impurity.json | R5: Any component of the drug product which is not the chemical entity defined as the drug substance, or an excipient in the drug product (new) | trial-use | 0 | fhir | 2026-03 | 4 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-MedicinalProductDefinition.indication.json | R5: Description of indication(s) for this product, used when structured indications are not required (new) | trial-use | 0 | fhir | 2026-03 | 4 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-MedicinalProductDefinition.ingredient.json | R5: The ingredients of this medicinal product - when not detailed in other resources (new) | trial-use | 0 | fhir | 2026-03 | 4 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-MPD.legalStatusOfSupply.json | R5: The legal status of supply of the medicinal product as classified by the regulator (new) | trial-use | 0 | fhir | 2026-03 | 2 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-MedicinalProductDefinition.marketingStatus.json | R5: Marketing status of the medicinal product, in contrast to marketing authorization (new) | trial-use | 0 | fhir | 2026-03 | 2 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-MedicinalProductDefinition.masterFile.json | R5: A master file for the medicinal product (e.g. Pharmacovigilance System Master File) (new) | trial-use | 0 | fhir | 2026-03 | 2 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-MPD.nam.par.type.json | R5: Identifying type for this part of the name (e.g. strength part) additional types | trial-use | 0 | fhir | 2026-03 | 2 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-MPD.nam.type.json | R5: Type of product name, such as rINN, BAN, Proprietary, Non-Proprietary (new) | trial-use | 0 | fhir | 2026-03 | 2 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-MPD.nam.usa.language.json | R5: language | trial-use | 0 | fhir | 2026-03 | 2 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-MedicinalProductDefinition.name.json | R5: The product's name, including full name and possibly coded parts (new) | trial-use | 0 | fhir | 2026-03 | 2 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-MedicinalProductDefinition.operation.json | R5: A manufacturing or administrative process for the medicinal product (new) | trial-use | 0 | fhir | 2026-03 | 4 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-MPD.pMP.json | R5: Package type for the product additional types | trial-use | 0 | fhir | 2026-03 | 4 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-MPD.pUI.json | R5: If authorised for use in children (new) | trial-use | 0 | fhir | 2026-03 | 4 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-MedicinalProductDefinition.route.json | R5: The path by which the product is taken into or makes contact with the body (new) | trial-use | 0 | fhir | 2026-03 | 4 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-MedicinalProductDefinition.specialMeasures.json | R5: specialMeasures additional types | trial-use | 0 | fhir | 2026-03 | 4 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-MedicinalProductDefinition.statusDate.json | R5: The date at which the given status became applicable (new) | trial-use | 0 | fhir | 2026-03 | 4 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-MedicinalProductDefinition.status.json | R5: The status within the lifecycle of this product record (new) | trial-use | 0 | fhir | 2026-03 | 4 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-MedicinalProductDefinition.type.json | R5: Regulatory type, e.g. Investigational or Authorized (new) | trial-use | 0 | fhir | 2026-03 | 2 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition/StructureDefinition-ext-R5-MedicinalProductDefinition.version.json | R5: A business identifier relating to a specific version of the product (new) | trial-use | 0 | fhir | 2026-03 | 4 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-MessageDefinition.all.message.json | R5: message additional types | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-MessageDefinition.base.json | R5: base additional types | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-MessageDefinition.contact.json | R5: contact additional types | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-MessageDefinition.event.json | R5: Event code or link to the EventDefinition additional types | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-MessageDefinition.foc.profile.json | R5: profile additional types | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-MessageDefinition.graph.json | R5: Canonical reference to a GraphDefinition (new) | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-MessageDefinition.parent.json | R5: parent additional types | trial-use | 0 | fhir | 2026-03 | 1 |
| hl7.fhir.uv.xver-r5.r3 | R3 | StructureDefinition/StructureDefinition-ext-R5-MessageDefinition.replaces.json | R5: replaces additional types | trial-use | 0 | fhir | 2026-03 | 1 |
FHIR IG analytics
FHIR
FHIRsmith